학술논문
Impact of daclizumab versus interferon beta-1a on patient-reported outcomes in relapsing-remitting multiple sclerosis
Document Type
Article
Author
Source
In Multiple Sclerosis and Related Disorders January 2017 11:18-24
Subject
Language
ISSN
2211-0348